Degranin Therapeutics, LLC

Biotechnology company · Louisville, Kentucky, United States

Degranin Therapeutics, LLC is a biotechnology company headquartered in Louisville, Kentucky, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $306,424 in total, most recently in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Degranin Therapeutics at a glance

Typebiotechnology company

HeadquartersLouisville, Kentucky, United States

Employees (self-reported, 2023)5

What does Degranin Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $306,424 in total (2023). NIH funding came from the National Heart, Lung, and Blood Institute.

Frequently asked questions about Degranin Therapeutics

Where is Degranin Therapeutics headquartered?

Degranin Therapeutics, LLC is headquartered in Louisville, Kentucky, United States.

What does Degranin Therapeutics do?

Degranin Therapeutics, LLC is a biotechnology company.

Similar companies

DesiCorp, Inc.Louisville, Kentucky, United States
ABT Molecular Imaging, Inc.Louisville, Tennessee, United States
Bolder Biotechnology IncLouisville, Colorado, United States
Endoprotech, Inc.Louisville, Kentucky, United States
Exscien CorporationLouisville, Kentucky, United States
Creosalus Inc.Louisville, Kentucky, United States
FasCure Therapeutics LLCLouisville, Kentucky, United States
Inflamed IncorporatedLouisville, Kentucky, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences